Analysis of humoral immune responses to LM1 ganglioside in guinea pigs

Journal of Neuroimmunology

Volumn 246, Issue 1-2, 2012, Pages 58-64

  Gu, Yajuan ^a   Chen, Zi Wei ^a   Siegel, Allan ^a   Koshy, Ranie ^a   Ramirez, Cristhian ^b   Raabe, Timothy D ^b   DeVries, George H ^c   Ilyas, Amjad A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b ST MARY'S UNIVERSITY   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

Guillain Barr syndrome; LM1 ganglioside antibodies; Myelin; Neuropathy; Schwann cells

Indexed keywords

FREUND ADJUVANT; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE LM1; GANGLIOSIDE LM1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; MYELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; FEMALE; GUINEA PIG; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOPATHOGENESIS; NEURITIS; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE;

ANIMALS; AUTOANTIBODIES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FREUND'S ADJUVANT; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; GUINEA PIGS; HEMOCYANIN; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; SCHWANN CELLS; SCIATIC NERVE;

EID: 84860135526     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.03.001     Document Type: Article

References (62)

1. Ando S., Kon K., Isobe M., Yamakawa T. Structural study on tetraglycosyl ceramide and gangliosides isolated from human red blood cells. J. Biochem. 1973, 73:893-895.
2. Asbury A.K., Arnason B.G., Adams R.D. The inflammatory lesion in idiopathic polyneuritis. Medicine 1969, 4:173-215.
3. Bancroft J.D., Gamble M. Theory and practice of histological techniques 2006, 371-414. Churchill Livingstone, Edinburgh. 5th Edition.
4. Benacerraf B., Ovary Z., Bloch K.J., Franklin E.C. Properties of guinea pig 7S antibodies. I. Electrophoretic separation of two types of guinea pig 7S antibodies. J. Exp. Med. 1963, 117:937-949.
5. Bloch K.J., Kourilsky F.M., Ovary Z., Benacerraf B. Properties of guinea pig 7S antibodies. III. Identification of antibodies involved in complement fixation and hemolysis. J. Exp. Med. 1963, 117:965-981.
6. Chou K.H., Nolan C.E., Jungalwala F.B. Subcellular fractionation of rat sciatic nerve and specific localization of ganglioside LM1 in rat nerve myelin. J. Neurochem. 1985, 44:1898-1912.
7. Cipriani B., Chen L., Hiromatsu K., Knowles H., Raine C.S., Battistini L., Porcelli S.A., Brosnan C.F. Upregulation of group 1 CD1 antigen presenting molecules in guinea pigs with experimental autoimmune encephalomyelitis: an immunohistochemical study. Brain Pathol. 2003, 13:1-9.
8. De Libero G., Mori L. Recognition of lipid antigens by T cells. Nat. Rev. 2005, 5:485-496.
9. Dowling P.C., Cook S.D. Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpes viruses in 41 cases. Ann. Neurol. 1981, 9:S44-S45.
10. Feasby T.E., Gilbert J.J., Brown W.F., Bolton C.F., Hahn A.F., Koopman W.F., Zochodone D.W. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986, 109:1115-1126.
11. Fisher M. Syndrome of ophthalmoplegia, ataxia and areflexia. N. Engl. J. Med. 1956, 255:57-65.
12. Fredman P., Vedeler C.A., Nyland H., Aarli J.A., Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculopathy react with ganglioside LM1 and sulfatide of peripheral nerve myelin. J. Neurol. 1991, 238:75-79.
13. Freimer M.L., McIntosh K., Adams R.A., Alving C.R., Drachman D.B. Gangliosides elicit a T-cell independent antibody response. J. Autoimmun. 1993, 6:281-289.
14. Griffin J.W., Li C.Y., Ho T.W., Xue P., Macko C., Gao C.Y., Yang C., Tian M., Mishu B., Cornblath D.R. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995, 118(Pt 3):577-595.
15. Gu Y., Chen Z.W., Siegel A., Ranie K., Raabe T., DeVries G., Ilyas A. Immune responses to neolactoganglioside LM1 in guinea pigs. XXth World Congress of Neurology 2011, 1120.
16. Hadden R.D., Gregson N.A., Gold R., Smith K.J., Hughes R.A. Accumulation of immunoglobulin across the "blood-nerve barrier" in spinal roots in adoptive transfer experimental autoimmune neuritis. Neuropathol. Appl. Neurobiol. 2002, 28:489-497.
17. Harukawa H., Utsumi H., Asano A., Yoshino H. Anti-LM1 antibodies in sera of patients with Guillain-Barré syndrome, Miller Fisher syndrome and motor neuron disease. J. Peripher. Nerv. Syst. 2002, 7:54-58.
18. Hiromatsu K., Dascher C.C., Sugita M., Gingrich-Baker C., Samuel M., Behar S.M., LeClair K.P., Brenner M.B., Porcelli S.A. Characterization of guinea pig group 1 CD1 proteins. Immunology 2002, 106:159-164.
19. Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., Asbury A.K., Blaser M.J., McKhann G.M. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995, 118(Pt 3):597-605.
20. Hsu S.M., Raine L., Fanger F. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981, 29:577-580.
21. Hughes R.A., Cornblath D.R. Guillain-Barré syndrome. Lancet 2005, 366:1653-1666.
22. Hughes R.A.C., Hadden R.D.M., Gregson N.A., Smith K.J. Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol. 1999, 100:74-97.
23. Ilyas A.A., Chen Z.W. Lewis rats immunized with GM1 ganglioside do not develop peripheral neuropathy. J. Neuroimmunol. 2007, 188:34-38.
24. Ilyas A.A., Dalakas M.C., Brady R.O., Quarles R.H. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes. Brain Res. 1986, 385:1-9.
25. Ilyas A.A., Willison H.J., Quarles R.H., Jungalwala F.B., Cornblath D.R., Trapp B.D., Griffin D.E., Griffin J.W., McKhann G.M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 1988, 23:440-447.
26. Ilyas A.A., Mithen F.A., Dalakas M.C., Wargo M., Chen Z.W., Cook S.D. Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J. Neurol. Sci. 1991, 105:108-117.
27. Ilyas A.A., Cook S.D., Dalakas M.C., Mithen F.A. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J. Neuroimmunol. 1992, 37:85-92.
28. Ilyas A.A., Mithen F.A., Chen Z.W., Cook S.D. Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 1992, 36:69-76.
29. Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.W., Cook S.D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 1992, 107:111-121.
30. Ilyas A.A., Cook S.D., Mithen F.A., Taki T., Kasama T., Handa S., Hamasaki H., Singhal B.S., Li S.C., Li Y.T. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome. J. Neuroimmunol. 1998, 8:160-167.
31. Ilyas A.A., Chen Z.W., Cook S.D., Mithen F.A., Singhal B.S. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barré syndrome. Res. Commun. Mol. Pathol. Pharmacol. 2001, 109:15-23.
32. Ilyas A.A., Gu Y., Dalakas M.C., Quarles R.H., Bhatt S. Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG. J. Neuroimmunol. 2008, 193:87-93.
33. Kuwabara S. Guillain-Barré syndrome: epidemiology, pathophysiology and management. Drugs 2004, 64(6):597-610.
34. Kuwahara M., Susuki S., Takada K., Kusunoki S. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 2011, 239:87-90.
35. Ledeen R.W., Yu R.K., Eng L.F. Gangliosides of human myelin: sialosyl-galactosylceramide (G7) as a major component. J. Neurochem. 1973, 21:829-839.
36. Li Y.T., Masson J.E., Vanier M.T., Svennerholm L. Structure of a major glucosamine containing ganglioside of human tissues. J. Biol. Chem. 1973, 248:2634-2636.
37. Lopez P.H., Villa A.M., Sica R.E., Nores G.A. High affinity as a disease determinant factor in anti-GM1 antibodies: comparative characterization of experimentally induced vs. disease associated antibodies. J. Neuroimmunol. 2002, 128:69-76.
38. McGrogan A., Madle G.C., Seaman H.E., de Vries C.S. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 2009, 32(2):150-163.
39. Mishu B., Ilyas A.A., Koski C.L., Vriesendorp F., Cook S.D., Mithen F.A., Blaser M.J. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann. Intern. Med. 1993, 118(12):947-953.
40. Norton W.T., Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 1973, 21:749-957.
41. O'Shannessy D.J., Ilyas A.A., Dalakas M.C., Mendell J.R., Quarles R.H. Specificity of human IgM monoclonal antibodies from patients with peripheral neuropathy. J. Neuroimmunol. 1986, 11:131-136.
42. Ogawa-Goto K., Abe T. Gangliosides and glycosphingolipids of peripheral nervous system myelin-a minireview. Neurochem. Res. 1998, 23:305-310.
43. Pollard J.D., Westland K.W., Harvey G.K., Jung S., Bonner J., Spies J.M., Toyka K.V., Hartung H.P. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann. Neurol. 1995, 37:467-475.
44. Porcelli S.A., Modlin R.L. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999, 17:297-329.
45. Prineas J.W. Acute idiopathic polyneuritis. An electron microscope study. Lab. Invest. 1972, 26:133-147.
46. Quarles R.H., Weiss M.D. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 1999, 22:800-822.
47. Quarles R.H., Ilyas A.A., Willison H.J. Antibodies to glycolipids in demyelinating diseases of the peripheral nervous system. Chem. Phys. Lipids 1986, 42:235-248.
48. Quarles R.H., Ilyas A.A., Willison H.J. Antibodies to gangliosides and to myelin proteins in Guillain-Barré syndrome. Ann. Neurol. 1990, 27:S48-S52.
49. Raabe T.D., Clive D.R., Neuberger T.J., Wen D., DeVries G.H. Cultured neonatal Schwann cells contain and secrete neuregulins in vitro. J. Neurosci. Res. 1996, 46:263-270.
50. Ramos-Alvarez M., Bessudo L., Sabin A.B. Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome. JAMA 1969, 207:1481-1492.
51. Rees J.H., Soudain S.E., Gregson N.A., Hughes R.A.C. A prospective case control study to investigate the relationship between Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 1995, 333:1374-1379.
52. Ropper A.H., Wijdicks E.F.M., Truax B.T. Guillain-Barré Syndrome 1991, F.A. Davis Company, Philadelphia.
53. Saida T., Saida K., Dorfman S.H., Silberberg D.H., Sumner A.J., Manning M.C., Lisak R.P., Brown M.J. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979, 204:1103-1106.
54. Sandberg A.L., Osler A.G., Shin H.S., Oliveira B. The biologic activities of guinea pig antibodies. II. Modes of complement interaction with γl and γ2 immunoglobulins. J. Immunol. 1970, 104:329-934.
55. Svennerholm L. Quantitation estimation of sialic acids. II. A colorometric resorcinol-hydrochloric acid method. Biochem. Biophys. Acta 1957, 24:604-609.
56. Svennerholm L., Bostrom K., Fredman P., Jungbjer B., Lekman A., Mansson J., Rynmark B. Gangliosides and allied glycosphingolipids in peripheral nerve and spinal cord. Biochim. Biophys. Acta 1994, 1214:115-123.
57. Vuagnat P. Further studies on the biologic properties of guinea pig IgGI antibodies. II. In vivo activation of C3 by anti-glomerular basement membrane antibodies. J. Immunol. 1975, 115:787-795.
58. Wherrett J.R. Characterization of the major ganglioside in human red cells and of a related tetrahexosyl ceramide in white cells. Biochim. Biophys. Acta 1973, 326(1):63-73. 17.
59. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002, 125:2591-2625.
60. Wirguin I., Briani C., Suturkova-Milosevic L., Fisher T., Della-Latta P., Chalif P., Latov N. Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides. J. Neuroimmunol. 1997, 78:138-142.
61. Yuki N. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr. Opin. Immunol. 2005, 17:577-582.
62. Yuki N., Tagawa Y., Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 1996, 70:1-6.